Press release
Anti-Rheumatics Market Size 2022: Demand, Growth Prospects and Forecast to 2027
Anti-Rheumatics Market Report 2022-2027
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Anti-rheumatics refer to the medications that are used for treating rheumatoid arthritis, a chronic inflammatory medical condition. Anti-rheumatic drugs are commonly prescribed by healthcare professionals to halt the disease progression. Apart from this, it is also utilized to treat inflammatory myositis, bowel diseases, and cancer.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/anti-rheumatics-market/requestsample
Anti-Rheumatics Market Trends and Drivers:
The global market is majorly driven by the increasing incidences of rheumatoid arthritis across the globe. Along with this, the widespread adoption of biosimilars and novel biologic therapies among the masses is also contributing to the market growth. Moreover, the rising prevalence of acute and chronic medical conditions, such as systemic sclerosis, systematic lupus erythematosus, and Sjogren syndrome, is providing a boost to the demand for anti-rheumatics across the globe. Other factors, including the increasing investments by public and private firms to upgrade the existing healthcare infrastructure and extensive research and development (R&D) activities conducted by key players, are driving the market growth further.
Anti-Rheumatics Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
AbbVie Inc. (ABBV)
Amgen Inc.
AstraZeneca plc
Biogen Inc.
Bristol-Myers Squibb Company
Celltrion Inc.
Eli Lilly and Company
F. Hoffmann-La Roche AG
Johnson & Johnsons
Pfizer Inc.
Sanofi SA.
Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/anti-rheumatics-market
The report has segmented the market on the basis of Type, Drug Class, Route of Drug Administration, Distribution Channel and Region.
Breakup by Type:
Prescription-based Drugs
Over-the-Counter Drugs
Breakup by Drug Class:
Disease Modifying Anti-Rheumatics Drugs (DMARD's)
Nonsteroidal Anti-Inflammatory Drugs (NSAID's)
Corticosteroids
Uric Acid Drugs
Others
Breakup by Route of Drug Administration:
Oral
Parenteral
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
E-Commerce
Breakup by Region:
North America
Asia-Pacific
Europe
Latin America
Middle East and Africa
Browse Other Reports by IMARC Group:
GCC Soft Skills Training Market 2022-2027: Share, Growth, Size, Trends and Analysis:- https://www.openpr.com/news/2633301/gcc-soft-skills-training-market-2022-2027-share-growth-size
Japan Casein Market 2022-2027: Share, Size, Growth, Trends and Forecast:- https://www.openpr.com/news/2633323/japan-casein-market-2022-2027-share-size-growth-trends
GCC Casein Market 2022-2027: Growth, Share, Trends, Analysis and Forecast:- https://www.openpr.com/news/2633332/gcc-casein-market-2022-2027-growth-share-trends-analysis
Europe Calcium Chloride Market 2022-2027: Growth, Size, Share, Trends and Analysis:- https://www.openpr.com/news/2633342/europe-calcium-chloride-market-2022-2027-growth-size-share
Europe Idiopathic Pulmonary Fibrosis Treatment Market 2022-2027: Trends, Growth, Size and Analysis:- https://www.openpr.com/news/2633351/europe-idiopathic-pulmonary-fibrosis-treatment-market
Europe Ferrite Magnet Market Size 2022-2027: Future Scope, Price Trends, Outlook and Forecast:- https://www.openpr.com/news/2667939/europe-ferrite-magnet-market-size-2022-2027-future-scope
Contact us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Website: https://www.imarcgroup.com
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Rheumatics Market Size 2022: Demand, Growth Prospects and Forecast to 2027 here
News-ID: 2686873 • Views: …
More Releases from IMARC Group
Potato Chips Market Size, Key Players, Demand, Industry Analysis and Forecast 20 …
Potato Chips Market 2025-2033:
• The global potato chips market size reached USD 35.2 Billion in 2024.
• The potato chips market size is expected to reach USD 44.0 Billion by 2033, exhibiting a growth rate (CAGR) of 2.5% during 2025-2033.
• Plain leads the market, accounting for the majority of the market share owing to its universal appeal and simple, classic taste.
• Supermarkets/hypermarkets represent the largest segment due to extensive availability and frequent promotional offers.
• The United…
Peanut Butter Market Size, Share, In-Depth Analysis and Forecast 2025-2033
Peanut Butter Market 2025-2033:
• The global peanut butter market reached USD 4.4 Billion in 2024.
• The peanut butter market size is expected to reach USD 4.4 Billion in 2024, exhibiting a growth rate (CAGR) of 4% during 2025-2033.
• North America leads the market, accounting for the largest peanut butter market share.
• Smooth peanut butter accounts for the majority of the market share in the product type segment due to its smooth texture and adaptability,…
UAE Online Grocery Market Size Worth USD 15.4 Billion by 2032 | CAGR: 21.60%: IM …
𝐔𝐀𝐄 𝐎𝐧𝐥𝐢𝐧𝐞 𝐆𝐫𝐨𝐜𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰
𝐁𝐚𝐬𝐞 𝐘𝐞𝐚𝐫: 2023
𝐇𝐢𝐬𝐭𝐨𝐫𝐢𝐜𝐚𝐥 𝐘𝐞𝐚𝐫𝐬: 2018-2023
𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐘𝐞𝐚𝐫𝐬: 2024-2032
𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 𝐢𝐧 𝟐𝟎𝟐𝟑: 𝐔𝐒𝐃 𝟐.𝟕 𝐁𝐢𝐥𝐥𝐢𝐨𝐧
𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 𝐢𝐧 𝟐𝟎𝟑𝟐: 𝐔𝐒𝐃 𝟏𝟓.𝟒 𝐁𝐢𝐥𝐥𝐢𝐨𝐧
𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟐: 𝟐𝟏.𝟔𝟎%
According to IMARC Group's report titled "𝐔𝐀𝐄 𝐎𝐧𝐥𝐢𝐧𝐞 𝐆𝐫𝐨𝐜𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟐," the market reached 𝐔𝐒𝐃 𝟐.𝟕 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑. Looking forward, IMARC Group expects the market to reach 𝐔𝐒𝐃 𝟏𝟓.𝟒 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, exhibiting a growth rate (CAGR) of 𝟐𝟏.𝟔𝟎%…
Report on Radial Tyre Manufacturing Plant Setup Requirements: Raw Materials, Mac …
IMARC Group's "Radial Tyre Manufacturing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" report provides a comprehensive guide on how to successfully set up a radial tyre manufacturing plant. The report offers clarifications on various aspects, such as unit operations, raw material requirements, utility supply, infrastructural needs, machinery models, labour necessities, transportation timelines, packaging costs, etc.
In addition to the operational aspects, the…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
